PPT-Pharmacotherapy Considerations in Sepsis and COVID-19

Author : RainbowGlow | Published Date : 2022-08-01

Eli Opacich PharmD BCPS BCCCP December 2 nd 2020 Financial Disclosures None Learning Objectives Assess pharmacotherapy updates in sepsis and septic shock Employ

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Pharmacotherapy Considerations in Sepsis..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Pharmacotherapy Considerations in Sepsis and COVID-19: Transcript


Eli Opacich PharmD BCPS BCCCP December 2 nd 2020 Financial Disclosures None Learning Objectives Assess pharmacotherapy updates in sepsis and septic shock Employ antimicrobial stewardship practices related . Stage 1. Source: world-sepsis-day.org . What is Sepsis?. Source: world-sepsis-day.org . Sepsis at a Glance. Sepsis is a . medical emergency . . . . . Source: . Advisory Board Company: “Why sepsis screening isn't one-size-fits-all” . COI Disclosures. Evans – Nothing to disclose. Thank You. Guidelines panelists. Group Heads. Methodologists. SCCM and ESICM . Participating societies. Reviewers. Dr. Phil Dellinger. Ms. Deb . Mcbride. Early recognition of Sepsis. Early Goal Directed Therapy . CASE. 6. 4yr . Samoan male. 24 . hr. . Fever, productive cough, SOB . and . delirium. Initial . Obs. HR 162, RR . 40, . sats. . 90% . on 15l, BP . Safe Schools. Sara Bode, MD. Conflict of Interest Disclosure. In the past 12 months, I have had the following financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s): None. September 16, 2021. COVID-19 Vaccination Clinical Considerations. Key points: Interim clinical considerations for COVID-19 vaccines. 2. COVID-19 vaccination is recommended for all people 12 years and older.. It’s not what you think. APTA Missouri Fall meeting. October 1, 2020. 10am - noon. 1. 1. PULMONARY EFFECTS OF COVID-19:. Speaker. :. . Sharon . C0ffman. . ellis. . . mmsc. . pt. ccs . SINCE 1983. Repurposed. . drugs. . and. . treatment. Steffen . Pelzl. , . PharmD. , . PhD. SLK-Kliniken Heilbronn GmbH. Heilbronn, Germany. Disclosure. Conflict. . of. . interest. : . nothing. . to. . disclose. Dr Avinash Agrawal. Prof & HOD. Dept. Of critical Care . M. edicine,. King . G. eorge’s . M. edical . U. niversity, UP, . L. ucknow. Brief Overview. There are . 7 different strains . of corona virus-. Sepsis is a potentially life-threatening condition, however it can be easily treated if caught early.. Symptoms of sepsis will present differently between adults and children. The information below is to help you identify the symptoms.. Print and display the pages as is or customize them with additional information or your facility’s logo (space allotted in the top right corner of each slide).. The content can be used on bulletin boards, in staff common areas, visitor reception areas, at staff or family council meetings and in mailings.. Sepsis Redefinition (Sepsis-3). February 23, 2016. Announced at the SCCM meeting in Orlando on February 22, 2016. Published in JAMA on February 23, 2016. http://www.tinyurl.com/2016sepsis. . The SIRS Criteria is valid to the extent that a systemic inflammatory response can be triggered by a variety of infectious and non-infectious conditions.. 16. th. . July. . 2020. Pauline . K. leinitz, Rehabilitation Programme. , WHO Headquarters . Why we need to consider rehabilitation?. Impact of COVID-19 on rehabilitation services . Survey Results of the WHO Rapid Assessment of Continuity of Essential Health Services. Sepsis,. . TNF-α. . Association. . with. . Mortality. . but. . not. . Sepsis. . Severity. . or. . Infection. . Source:. . a. . Systematic. . Review. and. . Meta-analysis. Amal. . A.. President and Chief Medical Officer. CDIMD – Physician Champions. Smyrna, Tennessee. jkennedy@cdimd.com. – (615) 479-7021. Sepsis Redefinition (Sepsis-3). February 23, 2016. Announced at the SCCM meeting in Orlando on February 22, 2016.

Download Document

Here is the link to download the presentation.
"Pharmacotherapy Considerations in Sepsis and COVID-19"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents